STEVEN J MEYER Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for STEVEN J MEYER.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of STEVEN J MEYER. STEVEN J MEYER is Director in AKORN INC ($AKRN.PK) and Treasurer in BAXTER INTERNATIONAL INC ($BAX) and Director in Insys Therapeutics, Inc. ($INSY).
Latest Insider Trading Transactions of STEVEN J MEYER
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AKRN.PK, BAX, INSY
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 04 2020 | AKRN.PK | AKORN INC | MEYER STEVEN J | Director | Buy | P | 1.08 | 85,000 | 91,800 | 130,225 | 45.2 K to 130.2 K (+187.95 %) |
| Mar 04 2020 | AKRN.PK | AKORN INC | MEYER STEVEN J | Director | Buy | P | 0.99 | 15,000 | 14,850 | 145,225 | 130.2 K to 145.2 K (+11.52 %) |
| Aug 15 2019 | AKRN.PK | AKORN INC | MEYER STEVEN J | Director | Buy | P | 2.70 | 10,000 | 27,000 | 173,154 | 163.2 K to 173.2 K (+6.13 %) |
| Aug 15 2019 | AKRN.PK | AKORN INC | MEYER STEVEN J | Director | Buy | P | 2.70 | 10,000 | 27,000 | 173,154 | 163.2 K to 173.2 K (+6.13 %) |
| Aug 15 2019 | AKRN.PK | AKORN INC | MEYER STEVEN J | Director | Buy | P | 2.50 | 10,000 | 25,000 | 183,154 | 173.2 K to 183.2 K (+5.78 %) |
| Aug 15 2019 | AKRN.PK | AKORN INC | MEYER STEVEN J | Director | Buy | P | 2.50 | 10,000 | 25,000 | 183,154 | 173.2 K to 183.2 K (+5.78 %) |
| May 30 2019 | AKRN.PK | AKORN INC | MEYER STEVEN J | Director | Buy | P | 3.75 | 10,000 | 37,500 | 163,154 | 153.2 K to 163.2 K (+6.53 %) |
| May 22 2019 | AKRN.PK | AKORN INC | MEYER STEVEN J | Director | Buy | P | 4.10 | 15,000 | 61,500 | 153,154 | 138.2 K to 153.2 K (+10.86 %) |
| May 13 2019 | AKRN.PK | AKORN INC | MEYER STEVEN J | Director | Option Exercise | A | 4.47 | 58,775 | 262,724 | 58,775 | |
| May 13 2019 | AKRN.PK | AKORN INC | MEYER STEVEN J | Director | Grant | A | 0.00 | 30,760 | 0 | 138,154 | 107.4 K to 138.2 K (+28.64 %) |
| Apr 23 2019 | INSY | Insys Therapeutics ... | MEYER STEVEN J | Director | Option Exercise | A | 6.36 | 20,935 | 133,147 | 20,935 | |
| Apr 23 2019 | INSY | Insys Therapeutics ... | MEYER STEVEN J | Director | Option Exercise | A | 8.06 | 16,000 | 128,960 | 16,000 | |
| Apr 23 2019 | INSY | Insys Therapeutics ... | MEYER STEVEN J | Director | Grant | A | 0.00 | 8,083 | 0 | 68,166 | 60.1 K to 68.2 K (+13.45 %) |
| Apr 23 2019 | INSY | Insys Therapeutics ... | MEYER STEVEN J | Director | Grant | A | 0.00 | 4,000 | 0 | 60,083 | 56.1 K to 60.1 K (+7.13 %) |
| Apr 19 2019 | INSY | Insys Therapeutics ... | MEYER STEVEN J | Director | Option Exercise | A | 6.36 | 20,935 | 133,147 | 20,935 | |
| Apr 19 2019 | INSY | Insys Therapeutics ... | MEYER STEVEN J | Director | Option Exercise | A | 8.06 | 16,000 | 128,960 | 16,000 | |
| Apr 19 2019 | INSY | Insys Therapeutics ... | MEYER STEVEN J | Director | Grant | A | 0.00 | 8,083 | 0 | 68,166 | 60.1 K to 68.2 K (+13.45 %) |
| Apr 19 2019 | INSY | Insys Therapeutics ... | MEYER STEVEN J | Director | Grant | A | 0.00 | 4,000 | 0 | 60,083 | 56.1 K to 60.1 K (+7.13 %) |
| Apr 19 2019 | INSY | Insys Therapeutics ... | MEYER STEVEN J | Director | Option Exercise | A | 6.36 | 20,935 | 133,147 | 20,935 | |
| Apr 19 2019 | INSY | Insys Therapeutics ... | MEYER STEVEN J | Director | Option Exercise | A | 8.06 | 16,000 | 128,960 | 16,000 | |
| Apr 19 2019 | INSY | Insys Therapeutics ... | MEYER STEVEN J | Director | Grant | A | 0.00 | 8,083 | 0 | 68,166 | 60.1 K to 68.2 K (+13.45 %) |
| Apr 19 2019 | INSY | Insys Therapeutics ... | MEYER STEVEN J | Director | Grant | A | 0.00 | 4,000 | 0 | 60,083 | 56.1 K to 60.1 K (+7.13 %) |
| May 10 2018 | INSY | Insys Therapeutics ... | MEYER STEVEN J | Director | Option Exercise | D | 0.00 | 4,000 | 0 | 0 | |
| May 10 2018 | INSY | Insys Therapeutics ... | MEYER STEVEN J | Director | Grant | A | 0.00 | 4,000 | 0 | 56,083 | 52.1 K to 56.1 K (+7.68 %) |
| May 10 2018 | INSY | Insys Therapeutics ... | MEYER STEVEN J | Director | Option Exercise | D | 0.00 | 4,000 | 0 | 0 | |
| May 10 2018 | INSY | Insys Therapeutics ... | MEYER STEVEN J | Director | Grant | A | 0.00 | 4,000 | 0 | 56,083 | 52.1 K to 56.1 K (+7.68 %) |
| Apr 23 2018 | AKRN.PK | AKORN INC | MEYER STEVEN J | Director | Grant | A | 0.00 | 14,189 | 0 | 107,394 | 93.2 K to 107.4 K (+15.22 %) |
| May 18 2017 | INSY | Insys Therapeutics ... | MEYER STEVEN J | Director | Buy | P | 12.21 | 8,000 | 97,680 | 52,083 | 44.1 K to 52.1 K (+18.15 %) |
| May 05 2017 | AKRN.PK | AKORN INC | MEYER STEVEN J | Director | Grant | A | 0.00 | 8,088 | 0 | 93,205 | 85.1 K to 93.2 K (+9.50 %) |
| Feb 23 2017 | INSY | Insys Therapeutics ... | MEYER STEVEN J | Director | Option Exercise | A | 0.00 | 4,000 | 0 | 4,000 | |
| Feb 23 2017 | INSY | Insys Therapeutics ... | MEYER STEVEN J | Director | Option Exercise | A | 12.65 | 16,000 | 202,400 | 16,000 | |
| Nov 07 2016 | INSY | Insys Therapeutics ... | MEYER STEVEN J | Director | Buy | P | 10.75 | 10,000 | 107,489 | 44,083 | 34.1 K to 44.1 K (+29.34 %) |
| Sep 01 2016 | INSY | Insys Therapeutics ... | MEYER STEVEN J | Director | Option Exercise | M | 13.57 | 500 | 6,785 | 6,000 | |
| Sep 01 2016 | INSY | Insys Therapeutics ... | MEYER STEVEN J | Director | Buy | M | 13.57 | 500 | 6,785 | 34,083 | 33.6 K to 34.1 K (+1.49 %) |
| Aug 04 2016 | INSY | Insys Therapeutics ... | MEYER STEVEN J | Director | Option Exercise | M | 13.57 | 500 | 6,785 | 6,500 | |
| Aug 04 2016 | INSY | Insys Therapeutics ... | MEYER STEVEN J | Director | Option Exercise | M | 14.44 | 694 | 10,021 | 22,917 | |
| Aug 04 2016 | INSY | Insys Therapeutics ... | MEYER STEVEN J | Director | Buy | M | 13.57 | 500 | 6,785 | 33,583 | 33.1 K to 33.6 K (+1.51 %) |
| Aug 04 2016 | INSY | Insys Therapeutics ... | MEYER STEVEN J | Director | Buy | M | 14.44 | 694 | 10,021 | 33,083 | 32.4 K to 33.1 K (+2.14 %) |
| Jul 06 2016 | AKRN.PK | AKORN INC | MEYER STEVEN J | Director | Option Exercise | A | 29.50 | 11,602 | 342,259 | 11,602 | |
| Jul 06 2016 | AKRN.PK | AKORN INC | MEYER STEVEN J | Director | Grant | A | 0.00 | 4,661 | 0 | 85,117 | 80.5 K to 85.1 K (+5.79 %) |
| Jul 06 2016 | INSY | Insys Therapeutics ... | MEYER STEVEN J | Director | Option Exercise | M | 14.44 | 695 | 10,036 | 23,611 | |
| Jul 06 2016 | INSY | Insys Therapeutics ... | MEYER STEVEN J | Director | Buy | M | 14.44 | 695 | 10,036 | 32,389 | 31.7 K to 32.4 K (+2.19 %) |
| Jun 07 2016 | INSY | Insys Therapeutics ... | MEYER STEVEN J | Director | Option Exercise | M | 14.44 | 694 | 10,021 | 24,306 | |
| Jun 07 2016 | INSY | Insys Therapeutics ... | MEYER STEVEN J | Director | Option Exercise | M | 13.57 | 500 | 6,785 | 7,000 | |
| Jun 07 2016 | INSY | Insys Therapeutics ... | MEYER STEVEN J | Director | Buy | M | 14.44 | 694 | 10,021 | 31,694 | 31 K to 31.7 K (+2.24 %) |
| Jun 07 2016 | INSY | Insys Therapeutics ... | MEYER STEVEN J | Director | Buy | M | 13.57 | 500 | 6,785 | 31,000 | 30.5 K to 31 K (+1.64 %) |
| Jun 06 2016 | AKRN.PK | AKORN INC | MEYER STEVEN J | Director | Option Exercise | M | 6.62 | 25,000 | 165,500 | 0 | |
| Jun 06 2016 | AKRN.PK | AKORN INC | MEYER STEVEN J | Director | Buy | M | 6.62 | 25,000 | 165,500 | 80,456 | 55.5 K to 80.5 K (+45.08 %) |
| May 18 2016 | INSY | Insys Therapeutics ... | MEYER STEVEN J | Director | Option Exercise | M | 13.57 | 500 | 6,785 | 7,500 | |
| May 18 2016 | INSY | Insys Therapeutics ... | MEYER STEVEN J | Director | Buy | M | 13.57 | 500 | 6,785 | 30,500 | 30 K to 30.5 K (+1.67 %) |
| May 04 2016 | INSY | Insys Therapeutics ... | MEYER STEVEN J | Director | Option Exercise | A | 14.44 | 25,000 | 361,000 | 25,000 | |
| Feb 09 2016 | INSY | Insys Therapeutics ... | MEYER STEVEN J | Director | Option Exercise | M | 3.63 | 9,500 | 34,485 | 50,500 | |
| Feb 09 2016 | INSY | Insys Therapeutics ... | MEYER STEVEN J | Director | Option Exercise | M | 13.57 | 8,500 | 115,345 | 9,500 | |
| Feb 09 2016 | INSY | Insys Therapeutics ... | MEYER STEVEN J | Director | Buy | M | 3.63 | 9,500 | 34,485 | 18,000 | 8.5 K to 18 K (+111.76 %) |
| Feb 09 2016 | INSY | Insys Therapeutics ... | MEYER STEVEN J | Director | Buy | M | 13.57 | 8,500 | 115,345 | 8,500 | 0 to 8.5 K |
| Apr 14 2016 | INSY | Insys Therapeutics ... | MEYER STEVEN J | Director | Option Exercise | M | 3.63 | 10,500 | 38,115 | 40,000 | |
| Apr 14 2016 | INSY | Insys Therapeutics ... | MEYER STEVEN J | Director | Option Exercise | M | 13.57 | 1,500 | 20,355 | 8,000 | |
| Apr 14 2016 | INSY | Insys Therapeutics ... | MEYER STEVEN J | Director | Buy | M | 3.63 | 10,500 | 38,115 | 30,000 | 19.5 K to 30 K (+53.85 %) |
| Apr 14 2016 | INSY | Insys Therapeutics ... | MEYER STEVEN J | Director | Buy | M | 13.57 | 1,500 | 20,355 | 19,500 | 18 K to 19.5 K (+8.33 %) |
| Jun 05 2015 | INSY | Insys Therapeutics ... | MEYER STEVEN J | Director | Sell | S | 63.00 | 5,000 | 315,000 | 0 | 5 K to 0 (-100.00 %) |
| May 11 2015 | INSY | Insys Therapeutics ... | MEYER STEVEN J | Director | Option Exercise | M | 3.25 | 18,000 | 58,500 | 16,425 | |
| May 11 2015 | INSY | Insys Therapeutics ... | MEYER STEVEN J | Director | Sell | S | 56.29 | 1,600 | 90,064 | 5,000 | 6.6 K to 5 K (-24.24 %) |
| May 11 2015 | INSY | Insys Therapeutics ... | MEYER STEVEN J | Director | Sell | S | 57.14 | 16,400 | 937,096 | 6,600 | 23 K to 6.6 K (-71.30 %) |
| May 11 2015 | INSY | Insys Therapeutics ... | MEYER STEVEN J | Director | Buy | M | 3.25 | 18,000 | 58,500 | 23,000 | 5 K to 23 K (+360.00 %) |
| May 07 2015 | INSY | Insys Therapeutics ... | MEYER STEVEN J | Director | Option Exercise | A | 53.50 | 9,000 | 481,500 | 9,000 | |
| Nov 20 2003 | BAX | BAXTER INTERNATION ... | MEYER STEVEN J | Treasurer | Option Exercise | A | 27.13 | 45,000 | 1,220,850 | 45,000 |
Page: 1